Get started
Live feed
·
SECFilingvia Quantisnow
CervoMed Inc. logo

CRVO: CervoMed Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for CRVO

Across the 18 sessions after earlier CRVO headlines, the stock closed higher 6 times and lower 11 times, with a median move of 3.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

CRVO close-to-close change in the session after earlier headlines
SessionEarlier headlineCRVOSPY
Jul 14, 2026CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)-6.9%+0.4%
Jul 9, 2026CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia+9.7%+0.8%
Jun 23, 2026CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules-9.9%-1.5%
Jun 18, 2026CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rulesand 1 other headline that session+11.3%+0.8%
Jun 12, 2026CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit+0.4%+0.5%
Jun 10, 2026CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies-22.1%-1.6%
Quantisnow market dataNASDAQ
CervoMed Inc. logo
CRVO
CervoMed Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for CRVO

Follow CRVO and get a push notification the moment its next story breaks.

Full CRVO profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRVO (CervoMed Inc.) and more on Quantisnow.